Study Completed

Common Cold, Sore Throat

Bayer Identifier:

11757

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

EU CT Number:

Not Available

ASPIRIN, relative bioavailability caplet vs. granules

Trial purpose

Please see attached Study Results Summary below

Key Participants Requirements

Sex

N/A

Age

18 - 45 Years

Trial summary

Enrollment Goal

Trial Dates

October 2004 - November 2004

Phase

Phase 1

Could I Receive a placebo

N/A

Products

Aspirin (Acetylsalicylic Acid, BAYE4465)

Accepts Healthy Volunteer

N/A

Where to participate

Status	Institution	Location
Completed	Institut für Klinische Pharmakologie, Prof. Lücker GmbH	Mannheim, 68167, Germany

Trial design

Open, randomized three-factorial (treatment-period-sequence), two-treatment, two-period, cross-over clinical bioequivalence-study for comparison of a fixed combination of 500 mg acetylsalicylic acid/30 mg pseudoephedrine (granules) versus a newly developed caplet formulation containing 500 mg acetylsalicylic acid/30 mg pseudoephedrine in 24 healthy male volunteers

Trial Type

Interventional

Intervention Type

N/A

Trial Purpose

N/A

Allocation

N/A

Blinding

N/A

Assignment

N/A

Trial Arms

N/A

Additional Information

Click here and search for drug information provided by the FDA.Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.